An interventional study of Practice Facilitation (PF) and Learning Collaborative (LC) in Risky Health Behavior, Substance Use Disorders and Substance Abuse, sponsored by Ohio State University. Active, not recruiting at 3 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-25.
Sponsored by Ohio State University · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Health Risk Behaviors with a site in United States — 6 open to participants now, 9 under way, none of them phase 3. Health Risk Behaviors · United States.
Among the 25 studies in Health Risk Behaviors with a site in United States, this one is the 12th largest by planned enrollment of the 24 interventional ones that give a count, is one of 2 that started in 2024, is one of 23 with no phase, and was the 21st registered.
60 studies on the registry are indexed under Health Risk Behaviors; 16 are open to participants now.
Browse Health Risk Behaviors studies →6 of the 25 studies in Health Risk Behaviors with a site in United States are open now. Recruiting first, the newest first:
San Francisco State University · Sites in United States
Ages 18+ · Healthy volunteers
Arizona State University · Sites in United States
Ages 12+ · Healthy volunteers
Shirish S Barve · Sites in United States
Ages 18–85 · Healthy volunteers
University of Michigan · Sites in United States
Ages 18+
Massachusetts General Hospital · Sites in United States
Ages 14–19
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 9 Health Risk Behaviors studies recruiting now, 5 set no upper age limit and 2 stop at 75 or younger; 1 takes children under 18; 4 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 1997; this study’s year is marked. 2 started in 2024.
This study's planned enrollment of 144 is close to the median of 144 across 47 interventional studies indexed under Health Risk Behaviors.
Median enrollment 138 across the 24 interventional studies, 10 across the 1 observational. Of the 16 that completed or were terminated, 5 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 25 have an industry lead sponsor. The 10 most frequent:
Ohio State University is the lead sponsor of 664 studies on the registry; 149 are open to participants now.
Of its 67 completed or terminated interventional studies of FDA-regulated products, 49 (73%) have results posted.
Ohio State University has 1 study filed under Health Risk Behaviors — fewer than ten, so there is no comparison to draw.
4 of the studies in Health Risk Behaviors with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06324318Arizona State UniversityParenting in 2 Worlds Multisite Trial | 2027-05-01 |
| NCT06524232Ohio State UniversityThe STop UNhealthy Substance Use Now Trial | 2027-09 |
| NCT06005298Shirish S BarveAlcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention | 2027-10-24 |
| NCT06206161Massachusetts General HospitalOptimizing and Advancing SBIRT in Schools | 2027-11-11 |
Add all 4 to your calendar (.ics) → With an account.
Among the 25 studies in Health Risk Behaviors with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The STop UNhealthy (STUN) Substance Use Now Trial (STUN II) is a multisite trial aiming to evaluate the comparative effectiveness of the following strategies for improving the implementation of screening and interventions for substance use disorders in primary care: practice facilitation (PF), PF plus a learning collaborative (LC), PF plus performance incentives (PI), and PF+LC+PI. We plan to enroll 144 clinic staff participants from 48 primary care practices
The STop UNhealthy (STUN) Substance Use Now Trial (STUN II) is a multisite trial aiming to evaluate the comparative effectiveness of the following strategies for improving the implementation of screening and interventions for substance use disorders in primary care: practice facilitation (PF), PF plus a learning collaborative (LC), PF plus performance incentives (PI), and PF+LC+PI. We plan to enroll 144 clinic staff participants from 48 primary care practices
Specific aim 1 (primary aim) will compare the effect of learning collaborative (LC) participation, performance incentives (PI), or their combination, with practice facilitation (PF) only, on implementation of evidence-based screening for SUDs.
Specific aim 2 (secondary aim) will compare the effect of LC participation, PI, or their combination, with PF only, on implementation of evidence-based interventions for SUDs, including (a) brief counseling, (b) medications (e.g., buprenorphine, naltrexone) and adherence to them, and (c) referral to specialty care.
Specific aims 1 and 2 will produce fundamentally important evidence about the comparative effectiveness of PF, PF+LC, PF+PI, and PF+LC+PI strategies on uptake of evidence-based screening and interventions for SUD when delivered to primary care practices.
Specific aim 3 (exploratory aim) will use a longitudinal mixed-methods evaluation to assess the association between implementation effectiveness and putative moderators (e.g., organizational readiness for change) and mediators (e.g., implementation climate). Aim 3 will generate scientific knowledge about mechanisms of change (why and how the various strategies work) in primary care settings.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Practice Facilitation: Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months.
Other: Practice Facilitation (PF)
Practice Facilitation (PF): Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Learning Collaborative (LC): Virtual LC sessions will be held monthly and will include participants presenting anonymized cases to clinical experts, targeted brief didactics related to the content of the cases, and time for open discussion and Q\&A.
Other: Practice Facilitation (PF) · Other: Learning Collaborative (LC)
Practice Facilitation: Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Performance Incentives: Practices will receive a maximum total of $6,000 based on their performance during the 12-month implementation period. They will have the opportunity to receive up to $1,500 per quarter if they reach performance milestones for the quarter.
Other: Practice Facilitation (PF) · Other: Performance Incentives (PI)
Practice Facilitation: Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Learning Collaborative (LC): Virtual LC sessions will be held monthly and will include participants presenting anonymized cases to clinical experts, targeted brief didactics related to the content of the cases, and time for open discussion and Q\&A. Performance Incentives: Practices will receive a maximum total of $6,000 based on their performance during the 12-month implementation period. They will have the opportunity to receive up to $1,500 per quarter if they reach performance milestones for the quarter.
Other: Practice Facilitation (PF) · Other: Learning Collaborative (LC) · Other: Performance Incentives (PI)
Practices will meet with practice facilitators monthly and apply tests of change using a Plan-Do-Study-Act approach, guided by the PF team. Facilitators will confirm that practices have established workflows for substance use disorder (SUD) screening and interventions and perform checks periodically to ensure progression. PF will entail: implementing protocols/algorithms for evidence-based screening and interventions, promoting decision support tools and templates to support practice workflow, optimizing electronic health record (EHR) use to pull clinical data monthly to guide the improvement process, developing patient registries (e.g., for those with SUD) to identify needed care and optimize delivery of evidence-based interventions, encouraging proactive, team-based care with assigned roles and responsibilities, and enhancing the understanding of evidence-based SUD interventions, including counseling and referral resources to ensure practices have appropriate intervention options.
Virtual LC sessions will be held monthly and will include participants presenting anonymized cases to clinical experts, targeted brief didactics related to the content of the cases, and time for open discussion and Q\&A. Participant-generated ideas for topics to be covered during virtual LC sessions will be encouraged. Some specific topics will include optimal SUD screening approaches; prescribing medications for opioid use disorder (OUD) in primary care; pragmatic issues around integrated SUD care within primary care such as compliance with state and federal requirements, note templates/visit frequency, and when/how to escalate care for patients with severe or worsening SUD; medications for alcohol use disorder (AUD); and motivational interviewing.
We will work closely with key stakeholders and the Steering Committee to co-design the PI strategy, refining the specific performance metrics to ensure that they align with other ongoing efforts in our partnering organizations. We plan to base the incentive on achieving a threshold target for the percentage of eligible adult patients screened for SUD, or the percentage improvement in screening, for quarters 1 and 2. For quarters 3 and 4, after practices have had time to implement and improve their processes for screening for SUD, the incentives will evolve to become a composite of (1) patients screened for SUD (the same as used in quarters 1 and 2) and (2) achieving a threshold target for the percentage of persons with SUD who received evidence-based interventions.
Number of adults screened for substance use disorder
Number of people aged 18 and older who are screened for substance use disorder using a validated screening tool
Time frame: 12 months
Percent of adults screened for substance use disorder
Percent of people aged 18 and older who are screened for substance use disorder using a validated screening tool
Time frame: 12 months
Number of adults with a positive screen for substance use disorder
Of those aged 18 and older who were screened for substance use disorder, number who had a positive screening result
Time frame: 12 months
Number of adults with a positive screen for substance use disorder
Of those aged 18 and older who were screened for substance use disorder, number who had a positive screening result
Time frame: 24 months
Percent of adults with a positive screen for substance use disorder
Of those aged 18 and older who were screened for substance use disorder, percentage who had a positive screening result
Time frame: 12 months
Percent of adults with a positive screen for substance use disorder
Of those aged 18 and older who were screened for substance use disorder, percentage who had a positive screening result
Time frame: 24 months
Number of adults who received any evidence-based intervention for substance use disorder
Of those aged 18 or older who were identified as having substance use disorder and/or alcohol use disorder, number who received brief counseling, medication, or referral to specialty care
Time frame: 12 months
Number of adults who received any evidence-based intervention for substance use disorder
Of those aged 18 or older who were identified as having substance use disorder and/or alcohol use disorder, number who received brief counseling, medication, or referral to specialty care
Time frame: 24 months
Percentage of adults who received any evidence-based intervention for substance use disorder
Of those aged 18 or older who were identified as having substance use disorder and/or alcohol use disorder, percentage that received brief counseling, medication, or referral to specialty care
Time frame: 24 months
Percentage of adults who received any evidence-based intervention for substance use disorder
Of those aged 18 or older who were identified as having substance use disorder and/or alcohol use disorder, percentage that received brief counseling, medication, or referral to specialty care
Time frame: 12 months
Number of adults who received brief counseling for substance use disorder
Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, number who received brief counseling
Time frame: 12 months
Number of adults who received brief counseling for substance use disorder
Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, number who received brief counseling
Time frame: 24 months
Percentage of adults who received brief counseling for substance use disorder
Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, percentage who received brief counseling
Time frame: 24 months
Percentage of adults who received brief counseling for substance use disorder
Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, percentage who received brief counseling
Time frame: 12 months
Number of adults who received medication for substance use disorder
Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, number who received medication
Time frame: 12 months
Number of adults who received medication for substance use disorder
Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, number who received medication
Time frame: 24 months
Percentage of adults who received medication for substance use disorder
Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, percentage who received medication
Time frame: 24 months
Percentage of adults who received medication for substance use disorder, including alcohol use disorder
Of people aged 18 or older who screened positive for substance use disorder and/or alcohol use disorder, percentage who received medication
Time frame: 12 months
Number of adults who received medication for substance use disorder, including alcohol use disorder, and adhered to 6 months of treatment
Of those aged 18 or older who received medication for substance use disorder and/or alcohol use disorder, number who adhered to treatment for 6 months
Time frame: 12 months
Number of adults who received medication for substance use disorder, including alcohol use disorder, and adhered to 6 months of treatment
Of those aged 18 or older who received medication for substance use disorder and/or alcohol use disorder, number who adhered to treatment for 6 months
Time frame: 24 months
Percentage of adults who received medication for substance use disorder, including alcohol use disorder, and adhered to 6 months of treatment
Of those aged 18 or older who received medication for substance use disorder and/or alcohol use disorder, percentage who adhered to treatment for 6 months
Time frame: 24 months
Percentage of adults who received medication for substance use disorder, including alcohol use disorder, and adhered to 6 months of treatment
Of those aged 18 or older who received medication for substance use disorder and/or alcohol use disorder, percentage who adhered to treatment for 6 months
Time frame: 12 months
Number of adults referred to specialty care for substance use disorder and/or alcohol use disorder
Of those aged 18 or older who were identified as having substance use disorder and/or alcohol use disorder, number who were referred to specialty care (psychiatry, 12-step programs, counseling, etc.)
Time frame: 12 months
Number of adults referred to specialty care for substance use disorder and/or alcohol use disorder
Of those aged 18 or older who were identified as having substance use disorder and/or alcohol use disorder, number who were referred to specialty care (psychiatry, 12-step programs, counseling, etc.)
Time frame: 24 months
Percentage of adults referred to specialty care for substance use disorder and/or alcohol use disorder
Of those aged 18 or older who were identified as having substance use disorder and/or alcohol use disorder, percentage who were referred to specialty care (psychiatry, 12-step programs, counseling, etc.)
Time frame: 24 months
Percentage of adults referred to specialty care for substance use disorder and/or alcohol use disorder
Of those aged 18 or older who were identified as having substance use disorder and/or alcohol use disorder, percentage who were referred to specialty care (psychiatry, 12-step programs, counseling, etc.)
Time frame: 12 months
Number of adults with alcohol use disorder
Of those aged 18 or older who were screened for substance use disorder, number who had alcohol use disorder
Time frame: 12 months
Number of adults with alcohol use disorder
Of those aged 18 or older who were screened for substance use disorder, number who had alcohol use disorder
Time frame: 24 months
Percentage of adults with alcohol use disorder
Of those aged 18 or older who were screened for substance use disorder, percentage who had alcohol use disorder
Time frame: 24 months
Percentage of adults with alcohol use disorder
Of those aged 18 or older who were screened for substance use disorder, percentage who had alcohol use disorder
Time frame: 12 months
Number of adults who received any evidence-based intervention for alcohol use disorder
Of those aged 18 or older identified as having alcohol use disorder, number who received any evidence-based intervention (brief counseling, medication, referral to specialty care)
Time frame: 12 months
Number of adults who received any evidence-based intervention for alcohol use disorder
Of those aged 18 or older identified as having alcohol use disorder, number who received any evidence-based intervention (brief counseling, medication, referral to specialty care)
Time frame: 24 months
Percentage of adults who received any evidence-based intervention for alcohol use disorder
Of those aged 18 or older identified as having alcohol use disorder, percentage who received any evidence-based intervention (brief counseling, medication, referral to specialty care)
Time frame: 24 months
Percentage of adults who received any evidence-based intervention for alcohol use disorder
Of those aged 18 or older identified as having alcohol use disorder, percentage who received any evidence-based intervention (brief counseling, medication, referral to specialty care)
Time frame: 12 months
Number of adults who received brief counseling for alcohol use disorder
Of those aged 18 or older identified as having alcohol use disorder, number who received brief counseling
Time frame: 12 months
Number of adults who received brief counseling for alcohol use disorder
Of those aged 18 or older identified as having alcohol use disorder, number who received brief counseling
Time frame: 24 months
Percentage of adults who received brief counseling for alcohol use disorder
Of those aged 18 or older identified as having alcohol use disorder, percentage who received brief counseling
Time frame: 24 months
Percentage of adults who received brief counseling for alcohol use disorder
Of those aged 18 or older identified as having alcohol use disorder, percentage who received brief counseling
Time frame: 12 months
Number of adults who received medication for alcohol use disorder
Of those aged 18 or older identified as having alcohol use disorder, number who received medication
Time frame: 12 months
Number of adults who received medication for alcohol use disorder
Of those aged 18 or older identified as having alcohol use disorder, number who received medication
Time frame: 24 months
Percentage of adults who received medication for alcohol use disorder
Of those aged 18 or older identified as having alcohol use disorder, percentage who received medication
Time frame: 24 months
Percentage of adults who received medication for alcohol use disorder
Of those aged 18 or older identified as having alcohol use disorder, percentage who received medication
Time frame: 12 months
Number of adults who received medication for alcohol use disorder and adhered to 6 months of treatment
Of those aged 18 or older who received medication for alcohol use disorder, number who adhered to treatment for 6 months
Time frame: 12 months
Number of adults who received medication for alcohol use disorder and adhered to 6 months of treatment
Of those aged 18 or older who received medication for alcohol use disorder, number who adhered to treatment for 6 months
Time frame: 24 months
Percentage of adults who received medication for alcohol use disorder and adhered to 6 months of treatment
Of those aged 18 or older who received medication for alcohol use disorder, percentage who adhered to treatment for 6 months
Time frame: 24 months
Percentage of adults who received medication for alcohol use disorder and adhered to 6 months of treatment
Of those aged 18 or older who received medication for alcohol use disorder, percentage who adhered to treatment for 6 months
Time frame: 12 months
Number of adults referred to specialty care for alcohol use disorder
Of those aged 18 or older who were identified as having alcohol use disorder, number who were referred to specialty care (psychiatry, 12-step programs, counseling, etc.)
Time frame: 12 months
Number of adults referred to specialty care for alcohol use disorder
Of those aged 18 or older who were identified as having alcohol use disorder, number who were referred to specialty care (psychiatry, 12-step programs, counseling, etc.)
Time frame: 24 months
Percentage of adults referred to specialty care for alcohol use disorder
Of those aged 18 or older who were identified as having alcohol use disorder, percentage who were referred to specialty care (psychiatry, 12-step programs, counseling, etc.)
Time frame: 24 months
Percentage of adults referred to specialty care for alcohol use disorder
Of those aged 18 or older who were identified as having alcohol use disorder, percentage who were referred to specialty care (psychiatry, 12-step programs, counseling, etc.)
Time frame: 12 months
Number of adults screened for substance use disorder
Number of people aged 18 and older who are screened for substance use disorder using a validated screening tool
Time frame: 24 months
Percent of adults screened for substance use disorder
Percent of people aged 18 and older who are screened for substance use disorder using a validated screening tool
Time frame: 24 months
Association between implementation effectiveness and putative moderators and mediators
Longitudinal mixed-methods evaluation (surveys, interviews) to describe the association between implementation effectiveness and putative moderators (e.g., organizational readiness for change) and mediators (e.g., implementation climate)
Time frame: 12 months
Association between implementation effectiveness and putative moderators and mediators
Longitudinal mixed-methods evaluation (surveys, interviews) to describe the association between implementation effectiveness and putative moderators (e.g., organizational readiness for change) and mediators (e.g., implementation climate)
Time frame: 24 months
Plan to share: No
Started Sep 2024 (actual). Primary completion is estimated for Sep 2027, 36 months after the start.
Of 36 non-industry interventional studies with no phase under Health Risk Behaviors, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's planned 36 months is above that.
Counting every sponsor, half of 37 studies reached it within 18 months; a quarter within 5 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.